An interventional study of Acute epidural stimulation for cardiovascular stability and Long Term Epidural Stimulation for Cardiovascular Stability in Spinal Cord Injuries, sponsored by University of Louisville. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-28.
Sponsored by University of Louisville · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Spinal Cord Injuries by University of Louisville — 9 open to participants now, 13 under way, none of them phase 3. Spinal Cord Injuries · University of Louisville.
Among the 22 studies in Spinal Cord Injuries by University of Louisville, this one is the 4th largest by planned enrollment of the 20 interventional ones that give a count, is the only one that started in 2017, is one of 18 with no phase, reaches primary completion later than 2 of the 12 other live ones, and was the 6th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →9 of the 22 studies in Spinal Cord Injuries by University of Louisville are open now, in 1 country. Recruiting first, the newest first:
University of Louisville · Sites in United States
Ages 18+
University of Louisville · Sites in United States
Ages 3–8
University of Louisville · Sites in United States
Ages 18+
University of Louisville · Sites in United States
Ages 18+
University of Louisville · Sites in United States
Ages 18–75
By country, each count listing its studies:
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2017.
This study's planned enrollment of 36 is above the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 12 across the 20 interventional studies, 3 across the 2 observational. Of the 8 that completed or were terminated, 4 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Louisville is the lead sponsor of 291 studies on the registry; 54 are open to participants now.
Of its 19 completed or terminated interventional studies of FDA-regulated products, 7 (37%) have results posted.
4 of the studies in Spinal Cord Injuries by University of Louisville that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04077346University of LouisvilleNeuromodulation of Spinal Locomotor Circuitry to Elicit Stepping After Pediatric Spinal Cord Injury | 2026-11 |
| NCT04032990University of LouisvilleTranscutaneous Spinal Stimulation: Safety and Feasibility for Upper Limb Function in Children With Spinal Cord Injury | 2026-12-18 |
| NCT06808035University of LouisvilleUnderstanding Perinatal Spinal Cord Injury | 2027-01 |
| NCT05178056University of LouisvilleSpinal Cord Stimulation and Respiration After Injury | 2027-02-28 |
Add all 4 to your calendar (.ics) → With an account.
Among the 22 studies in Spinal Cord Injuries by University of Louisville, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The investigators propose to understand the role of lumbosacral spinal cord epidural stimulation (scES) in recovery of autonomic nervous system function, voluntary movement, and standing in individuals with severe spinal cord injury (SCI). Thirty-six individuals with severe SCI who have cardiovascular and respiratory dysfunction and who are unable to voluntarily move the legs or stand will receive scES for cardiovascular function, voluntary movement, or standing with and/or without weight-bearing standing. Training will consist of practicing voluntary movements or standing in the presence of specific scES configurations designed for the voluntary movements of the legs and trunk (Vol-scES), or epidural stimulation configurations specific for standing (Stand-scES). Specific configurations epidural stimulation for cardiovascular function (CV-scES) will be provided during sitting and supine and during maneuvers of orthostatic or cardiovascular stress. The ability to move voluntarily, stand, as well as cardiovascular, respiratory, bladder, bowel and sexual function will be assessed in these individuals with chronic severe spinal cord injury. Quality of life and costs of health care also will be assessed.
Experimental Design
The investigators will enroll, implant and complete the interventions in 36 research participants who have sustained a SCI in the proposed experiments. The investigators anticipate they will need to screen 108 potential research participants to enroll 36 individuals who will complete the study. This sample size will provide sufficient replication per study group (n=4) from which variance and effect size estimates for each study hypothesis can be calculated, and hypothesis tests conducted. The investigators will also select individuals to assure that there are a minimum of 25% (n=9) women to adequately represent the percentage in the SCI population. The investigators will study each cohort of patients comprehensively, and each individual will be allocated to the group interventions based on the method of minimization. Research participants will be randomized into group interventions. This novel approach of conducting repeated experiments with comprehensive assessments in a smaller cohort of patients, rather than a more traditional approach of including a large number of patients and focusing on a single outcome, will advance both clinical and scientific knowledge in this highly complex population. The investigators have found success with the smaller cohort approach because they can employ more rigorous, quantitative and sensitive outcomes that not only inform them about the potential clinical efficacy, but also provide further knowledge of the mechanisms of neural control of movement and other physiological mechanisms related to cardiovascular, respiratory, bladder, bowel and sexual function.
Group A:
Group B:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants are assessed both with and without epidural stimulation for cardiovascular stability for persistent hypotension, orthostatic hypotension and autonomic dysreflexia.
Device: Acute epidural stimulation for cardiovascular stability
Participants assigned to this arm will receive be randomized to receive epidural stimulation specific for cardiovascular function alone or cardiovascular function and standing, or voluntary movement alone or voluntary movement and standing.
Device: Long Term Epidural Stimulation for Cardiovascular Stability
Participants assigned to this group will receive epidural stimulation specific for voluntary movement and will also receive stand training.
Device: Participants undergo approximately 4 months of epidural stimulation for voluntary movement plus stand training.
Participants assigned to this group will receive epidural stimulation specific for cardiovascular function and will also receive stand training.
Device: Long Term Epidural Stimulation for Cardiovascular Stability plus Stand Training
Participants assigned to this group receive epidural stimulation specifically for voluntary movement.
Device: Participants undergo approximately 4 months of epidural stimulation for voluntary movement.
Eligible participants will be implanted with 16-electrode epidural array and epidural stimulator in the spinal cord. Participants received mapping for cardiovascular stability.
Participants undergo approximately 4 months of epidural stimulation for cardiovascular stability, daily.
Participants undergo approximately 4 months of epidural stimulation for voluntary movement 4-7 days weekly.
Participants undergo approximately 4 months of epidural stimulation for cardiovascular stability, daily. Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame with epidural stimulation for standing up to 5 days weekly.
Participants undergo approximately 4 months of epidural stimulation for voluntary movement, 4-7 days weekly. Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame with epidural stimulation for standing up to 5 days weekly. Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame with epidural stimulation for standing up to 5 days weekly.
Recovery of autonomic control of cardiovascular function as assessed by cardiovascular assessments
Time frame: up to 20 months
Recovery of voluntary movement as assessed by functional movement assessments
Time frame: up to 20 months
Plan to share: No — There is no plan to share individual participant data.
Started Nov 2017 (actual). Primary completion is estimated for Dec 2024, 85 months after the start.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 85 months is above that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.